6260Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55
Albania medical device registration · Abbott Laboratories Diagnostics Division, Abbott Park, Illinois 60064 USA · Invitro · Model Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55 · Registered October 29, 2019
- Risk Class
- Invitro
- Product Model
- Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55
- Product Name
- Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55
- Registration Date
- October 29, 2019
- Analysis ID
- 6260
Sherben per ekstraktimin e Tacrolimus nga mostrat (kampione nga gjaku I plote I njeriut, kontrollet dhe kalibratoret Architect Cyclosporine) qe do te testohen ne sistemet ARCHITECT
Access comprehensive regulatory information for Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55 in the Albania medical device market through Pure Global AI's free database. This Invitro medical device is manufactured by Abbott Laboratories Diagnostics Division, Abbott Park, Illinois 60064 USA. The device was registered on October 29, 2019.
This page provides complete registration details including product model (Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.